Shares of Kythera Biopharmaceuticals Inc. popped nearly 9 percent on Friday after the company announced in its earnings statement that it planned to seek approval to sell its first pipeline drug in foreign countries....

Join our Membership to get the full story.


Are you a current Member? Sign In